HSF1 inhibition induces pancreatic ductal adenocarcinoma autophagy through JNK

被引：0
|
作者：
Ghai, Shruti
Young, Alex
Su, Kuo-Hui
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4319
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impaired Autophagy Associates with HSF1 Proteostasis Factor to Cause Hepatic Proteinopathy
    Byrnes, Katherine G.
    Blessinger, Sophia A.
    Bailey, Niani
    Scaife, Russell F.
    Liu, Gang
    Khambu, Bilon
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (12): : S24 - S24
  • [22] Downregulation of ZNF395 enhances cell proliferation in pancreatic ductal adenocarcinoma through inactivation of JNK
    Kurogi, Shusaku
    Hijiya, Naoki
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Inomata, Masafumi
    Kobayashi, Takashi
    Moriyama, Masatsugu
    CANCER SCIENCE, 2022, 113 : 567 - 567
  • [23] MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma
    New, Maria
    Van Acker, Tim
    Sakamaki, Jun-Ichi
    Jiang, Ming
    Saunders, Rebecca E.
    Long, Jaclyn
    Wang, Victoria M-Y
    Behrens, Axel
    Cerveira, Joana
    Sudhakar, Padhmanand
    Korcsmaros, Tamas
    Jefferies, Harold B. J.
    Ryan, Kevin M.
    Howell, Michael
    Tooze, Sharon A.
    CANCER RESEARCH, 2019, 79 (08) : 1884 - 1898
  • [24] JNK MAPK Inhibition Reprograms Stromal Inflammation and the Immunosuppressive Tumor Microenvironment to Enhance Chemosensitivity in Pancreatic Ductal Adenocarcinoma
    Box, Edmond W., III
    Singh, Samara
    Mehra, Siddharth
    Amirian, Haleh
    Bianchi, Anna
    Adams, Andrew M.
    Carriere, Candace H.
    Nagathihalli, Nagaraj S.
    Datta, Jashodeep
    Merchant, Nipun B.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S284 - S284
  • [25] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Pieper, Noah L.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (02)
  • [27] Dual inhibition of HSF1 and DYRK2 impedes cancer
    Tandon, Vasudha
    Moreno, Rita
    Allmeroth, Kira
    Quinn, Jean
    Wiley, Sandra E.
    Nicely, Lynden G.
    Denzel, Martin S.
    Edwards, Joanne
    de la Vega, Laureano
    Banerjee, Sourav
    BIOSCIENCE REPORTS, 2023, 43 (01) : 1 - 14
  • [28] Attenuation of exercise conditioning by metformin-a consequence of HSF1 inhibition
    Hooper, Philip L.
    CELL STRESS & CHAPERONES, 2022, 27 (04): : 307 - 307
  • [29] Inhibition of HSF1 demonstrates therapeutic efficacy in preclinical models of cholangiocarcinoma
    Carlson, Danielle M.
    Abdelrahman, Amro
    Fogliati, Alessandro
    Lynch, Isaac
    Tomlinson, Jennifer
    Truty, Mark
    Smoot, Rory
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Organoid Assessment of IL-1 Inhibition in Human Pancreatic Ductal Adenocarcinoma
    Morgan, Annah
    Griffin, Michelle
    Guo, Chuner
    Parker, Jennifer B. L.
    Januszyk, Michael
    Foster, Deshka S.
    Poultsides, George A.
    Delitto, Daniel
    Longaker, Michael T.
    Norton, Jeffrey A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S451 - S452
12345